- Home
- OSCR
OSCR
Oscar Health Inc.
as 08-22-2025 4:00pm EST
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 3.2B | IPO Year: | 2021 |
| Target Price: | $12.07 | AVG Volume (30 days): | 19.9M |
| Analyst Decision: | Sell | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.20 - $23.79 | Next Earning Date: | 08-06-2025 |
| Revenue: | $10,726,126,000 | Revenue Growth: | 48.29% |
| Revenue Growth (this year): | 31.12% | Revenue Growth (next year): | -6.01% |
Latest Oscar Health Inc. News
OSCR Breaking Stock News: Dive into OSCR Ticker-Specific Updates for Smart Investing
Motley Fool
2 months ago
2 Incredible Growth Stocks I'd Buy Right Now
Investor's Business Daily
2 months ago
Key GOP Health Care Cuts Ruled Out Of Bounds; UNH, HCA Jump — Briefly
Zacks
2 months ago
Oscar Health, Inc. (OSCR) Stock Moves -4.15%: What You Should Know
MT Newswires
2 months ago
Raymond James Downgrades Oscar Health to Market Perform From Outperform
Zacks
2 months ago
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
Insider Monkey
2 months ago
Oscar Health (OSCR) Skyrockets 52% W/W. Time to Take Profits?
Insider Monkey
2 months ago
Oscar Health (OSCR) Soars 13% on Fourth Straight Day, Here’s Why
GuruFocus.com
2 months ago
Retail Traders Just Sent This AI Health Stock Soaring 60%
Compare OSCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OSCR Oscar Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.